Mucofan® – For Oral Mucositis; Efficacy
Mucofan contains a Live, Probiotic: Lactobacillus brevis CD2
Not less than 2 Billion CFUs per Chew Tab
Muocfan is used for management of existing oral mucositis and for prevention and amelioration of oral mucositis associated with CRT
Mucofan is available as easy to use, oral chewable tablets and can be used during and even before start of CRT for better results
Long Term I.P. Protection for Mucofan – U.S. Patent under application
Significantly cost effective and highly effective for Oral Mucositis
API has GRAS notification from US FDA
API (Lactobacillus brevis CD2) is Approved as Orphan Drug in Bechet’s Disease by US FDA
Mucofan® – Mechanism of Action
